AMBRISENTAN 
| AMBRISENTAN | ATC C02KX02 ATC C02KX52
CARDIOVASCULAR ANTIHYPERTENSIVE ENDOTHELIN RECEPTOR ANTAGONIST TREATMENT OF PULMONARY ARTERIAL HYPERTENSION (PAH) AMBRISENTAN IS A SUBSTRATE OF P-GP | ORAL | Cmax 912 NANOMOLAR Tmax 1.5 HOUR PPB 99 PERCENT Cl 1.71 LITER / HOUR HT 9 HOUR SOLUBILITY PRACTICALLY INSOLUBLE IN WATER | ENDOTHELIN TYPE-A RECEPTOR (ETA) (KI = 0.011 NANOMOLAR) PDB 8XVK (CRYO-EM STRUCTURE OF ETAR BOUND WITH AMBRISENTAN) LIGAND CODE = A1D5J (link to the list of PDB complexes) Download experimental 3D coordinates of A1D5J with added hydrogens | Endothelin-1 receptor UNIPROT P25101 EDNRA more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com VigiAccess SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |